Related Experiment Video

Updated: May 16, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

Antithrombotic therapy: triple therapy or triple threat?

Jessica Mega1, Edward T Carreras

  • 1Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. jmega@partners.org

Hematology. American Society of Hematology. Education Program
|December 13, 2012
PubMed

Insights

Triple oral antithrombotic therapy (TOAT) combines anticoagulation and antiplatelet drugs. Newer agents may offer safer alternatives to warfarin, but careful risk-benefit assessment is crucial for optimal patient outcomes.

Area of Science:

  • Cardiology
  • Pharmacology
  • Internal Medicine

Background:

  • Antithrombotic therapy is vital for managing prevalent and serious medical conditions.
  • Triple oral antithrombotic therapy (TOAT) involves oral anticoagulation (OAC) plus dual antiplatelet therapy (DAPT).
  • Current guidelines for TOAT primarily stem from observational data and older warfarin-based trials.

Purpose of the Study:

  • To review the current landscape of triple oral antithrombotic therapy (TOAT).
  • To explore the role of newer anticoagulant agents in TOAT regimens.
  • To discuss the balance of efficacy and bleeding risks associated with TOAT.

Main Methods:

  • Review of existing societal guidelines and clinical trial data.
  • Analysis of studies involving warfarin and newer oral anticoagulants in patients requiring OAC and DAPT.
  • Evaluation of pharmacokinetic properties and bleeding concerns associated with antithrombotic agents.

Main Results:

  • Warfarin-based TOAT is associated with significant bleeding risks, partly due to its pharmacokinetic profile.
  • Emerging data from recent trials using newer anticoagulants in atrial fibrillation and acute coronary syndromes offer insights into TOAT.
  • The use of novel oral anticoagulants in TOAT requires further investigation to establish optimal use.

Conclusions:

  • The established apprehension towards TOAT is largely due to bleeding concerns, particularly with warfarin.
  • Newer anticoagulant agents present potential advantages over warfarin for TOAT.
  • Individualized patient assessment, weighing bleeding and thrombotic risks, is essential for selecting the optimal antithrombotic strategy.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...